Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor
-
Published:2024-04-09
Issue:1
Volume:22
Page:
-
ISSN:1478-811X
-
Container-title:Cell Communication and Signaling
-
language:en
-
Short-container-title:Cell Commun Signal
Author:
Ho Shannon J.,Chaput Dale,Sinkey Rachel G.,Garces Amanda H.,New Erika P.,Okuka Maja,Sang Peng,Arlier Sefa,Semerci Nihan,Steffensen Thora S.,Rutherford Thomas J.,Alsina Angel E.,Cai Jianfeng,Anderson Matthew L.,Magness Ronald R.,Uversky Vladimir N.,Cummings Derek A. T.,Tsibris John C. M.
Abstract
AbstractVEGFR2 (Vascular endothelial growth factor receptor 2) is a central regulator of placental angiogenesis. The study of the VEGFR2 proteome of chorionic villi at term revealed its partners MDMX (Double minute 4 protein) and PICALM (Phosphatidylinositol-binding clathrin assembly protein). Subsequently, the oxytocin receptor (OT-R) and vasopressin V1aR receptor were detected in MDMX and PICALM immunoprecipitations. Immunogold electron microscopy showed VEGFR2 on endothelial cell (EC) nuclei, mitochondria, and Hofbauer cells (HC), tissue-resident macrophages of the placenta. MDMX, PICALM, and V1aR were located on EC plasma membranes, nuclei, and HC nuclei. Unexpectedly, PICALM and OT-R were detected on EC projections into the fetal lumen and OT-R on 20–150 nm clusters therein, prompting the hypothesis that placental exosomes transport OT-R to the fetus and across the blood–brain barrier. Insights on gestational complications were gained by univariable and multivariable regression analyses associating preeclampsia with lower MDMX protein levels in membrane extracts of chorionic villi, and lower MDMX, PICALM, OT-R, and V1aR with spontaneous vaginal deliveries compared to cesarean deliveries before the onset of labor. We found select associations between higher MDMX, PICALM, OT-R protein levels and either gravidity, diabetes, BMI, maternal age, or neonatal weight, and correlations only between PICALM-OT-R (p < 2.7 × 10–8), PICALM-V1aR (p < 0.006), and OT-R-V1aR (p < 0.001). These results offer for exploration new partnerships in metabolic networks, tissue-resident immunity, and labor, notably for HC that predominantly express MDMX.
Funder
Department of Obstetrics and Gynecology, University of South Florida Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida Lisa Muma Weitz Microscopy Laboratory, University of South Florida Department of Chemistry, University of South Florida Tampa General Hospital, Tampa, Florida Teasley Foundation Department of Molecular Medicine, University of South Florida Department of Biology, University of Florida Emerging Pathogens Institute, University of Florida
Publisher
Springer Science and Business Media LLC
Reference96 articles.
1. Burton GJ, Fowden AL. The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015;370(1663):20140066. https://doi.org/10.1098/Rstb.2014.0066. 2. Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-Eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:L2381. https://doi.org/10.1136/Bmj.L2381. 3. Aplin JD, Myers JE, Timms K, Westwood M. Tracking placental development in health and disease. Nat Rev Endocrinol. 2020;16(9):479–94. https://doi.org/10.1038/S41574-020-0372-6. 4. Shibuya M. Vegfr and type-V Rtk activation and signaling. Cold Spring Harb Perspect Biol. 2013;5(10):A009092. https://doi.org/10.1101/Cshperspect.A009092. 5. Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., Et Al. (2018). Molecular Pharmacology Of Vegf-A Isoforms: Binding And Signalling At Vegfr2. Int J Mol Sci, 19(4) https://doi.org/10.3390/Ijms19041264.
|
|